p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

Source:http://linkedlifedata.com/resource/pubmed/id/18291508

Download in:

View as

General Info

PMID
18291508